# Biote Corp. (BTMD)

**Exchange:** NASDAQ  
**Sector:** Healthcare  
**Market cap:** $89M  
**Price:** $2.42 (+6.83%)

> Biote Corp. is a healthcare company specializing in hormone optimization and preventive medicine. It operates a comprehensive practice-building platform known as the Biote Method, which equips certified practitioners with education, training, certification, practice management software, inventory management tools, and digital marketing support to deliver bioidentical hormone replacement pellet therapy. This therapy addresses hormonal imbalances in men and women, promoting therapeutic wellness and healthy aging. Biote Corp. also offers Biote-branded dietary supplements and sterile pellet insertion kits essential for hormone optimization treatments. The company supports a network of physicians and nurse practitioners, enabling them to implement personalized hormone therapy programs effectively. Through its end-to-end solutions, Biote Corp. plays a key role in the growing hormone optimization sector within preventive healthcare. Founded in 2012 and headquartered in Irving, Texas, it focuses on empowering providers to optimize patient hormone levels using precise, bioidentical approaches.

## Income Statement (Annual, USD)

| Fiscal Year | Revenue | Gross Profit | Operating Income | Net Income | EPS (dil.) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $192M | — | $36M | $27M | — |
| 2024 | $197M | — | $32M | $3M | — |
| 2023 | $185M | — | $29M | $3M | — |
| 2022 | $165M | — | -$61M | -$969,000 | — |
| 2021 | $139M | — | $35M | $11M | — |

## Balance Sheet (Annual, USD)

| Fiscal Year | Total Assets | Total Liabilities | Equity | Cash | Long-term Debt |
| --- | --- | --- | --- | --- | --- |
| 2025 | $108M | $158M | -$59M | $24M | $103M |
| 2024 | $122M | $225M | -$106M | $39M | $109M |
| 2023 | $155M | $192M | -$29M | $89M | $116M |
| 2022 | $112M | $170M | -$44M | $79M | $122M |
| 2021 | $54M | $50M | $4M | $130,359 | $32M |

## Cash Flow (Annual, USD)

| Fiscal Year | Operating Cash Flow | CapEx | Free Cash Flow |
| --- | --- | --- | --- |
| 2025 | $35M | $5M | $30M |
| 2024 | $45M | $6M | $39M |
| 2023 | $27M | $359,000 | $27M |
| 2022 | -$9M | $333,000 | -$9M |
| 2021 | $34M | $1M | $32M |

Source: [CompaniesByCap](https://companiesbycap.com/company/BTMD)